Abstract PO-092: Expanded access trial of tocilizumab in COVID19+ hospitalized cancer patients
Go back to Resource Center
Abstract PO-092: Expanded access trial of tocilizumab in COVID19+ hospitalized cancer patients
Authors:
Volume:
Pagination:
Issue:
Journal:
Keywords:
Abstract: